Disclaimers

Huaju Biotechnology's products are under development. They have not received marketing approval from the National Medical Products Administration (NMPA) or any other regulatory authority, and are not currently available for sale. Nothing on this site should be interpreted as a claim of regulatory approval or as an offer to sell any product.

Statements describing our technology and pipeline reflect research and development progress, including preclinical work, and do not represent demonstrated clinical outcomes.

Content on this site, including descriptions of medical conditions and technologies, is for general information only and is not medical advice. It is not a substitute for consultation with a qualified healthcare professional. Do not rely on this site to diagnose or treat any condition.

This site contains forward-looking statements, including statements about development timelines, regulatory plans, market opportunity, and future products. These statements reflect current expectations and assumptions and involve risks and uncertainties. Actual results may differ materially, and we undertake no obligation to update them except as required by law.

Nothing on this site constitutes an offer to sell, or a solicitation of an offer to buy, any securities, nor investment, financial, or legal advice. Any investment-related discussions are conducted separately and subject to applicable law.

Market figures and projections on this site are drawn from third-party sources and internal estimates believed to be reliable but not independently verified. They are provided for context only and are not a guarantee of future performance.

Questions about these disclaimers can be directed to info@huaju.co.